Chugai Pharmaceutical Co. Ltd.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)19.72%
Cost of Goods Sold (US$ Millions)$1,996
Current Liabilities (US$ Millions)$1,105
Total Assets (US$ Millions)$4,717
Long Term Debt$5
Return on Equity10.25%
Revenue (US$ Millions)$4,144
Total Company Assets$6,541
Revenue Growth (%)8.18%
Net Income (US$ Millions)$508
Earnings Per Share (US$)$19.72
Total Equity (US$ Millions)$5,199
Profit Margin (%)12.25%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$1,339